Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Implication of Repeat Insertion Domains in the Trans-Activity of the Long non-coding RNA ANRIL

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Homo sapiens

PROVIDER: GSE162224 | GEO | 2021/05/26

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Implication of repeat insertion domains in the trans-activity of the long non-coding RNA ANRIL.

Project description:Long non-coding RNAs have emerged as critical regulators of cell homeostasis by modulating gene expression at chromatin level for instance. Here, we report that the lncRNA ANRIL, associated with several pathologies, binds to thousands of loci dispersed throughout the mammalian genome sharing a 21-bp motif enriched in G/A residues. By combining ANRIL genomic occupancy with transcriptomic analysis, we established a list of 65 and 123 genes potentially directly activated and silenced by ANRIL in trans, respectively. We also found that Exon8 of ANRIL, mainly made of transposable elements, contributes to ANRIL genomic association and consequently to its trans-activity. Furthermore, we showed that Exon8 favors ANRIL's association with the FIRRE, TPD52L1 and IGFBP3 loci to modulate their expression through H3K27me3 deposition. We also investigated the mechanisms engaged by Exon8 to favor ANRIL's association with the genome. Our data refine ANRIL's trans-activity and highlight the functional importance of TEs on ANRIL's activity.

| S-EPMC8136789 | biostudies-literature

Implication of repeat insertion domains in the trans-activity of the long non-coding RNA ANRIL [ANRIL_LNA_Affy]

Project description:To identify the genes differentially expressed upon the knockdown of the lncRNA ANRIL using LNA GapmeRs in HEK293 cells

2021-05-26 | GSE162223 | GEO

Implication of Repeat Insertion Domains in the Trans-Activity of the Long non-coding RNA ANRIL [ANRIL_DEx8_Affy]

Project description:To identify the genes differentially expressed upon removal of the Exon8 of the lncRNA ANRIL in HEK293 cells

2021-05-26 | GSE162222 | GEO

Implication of Repeat Insertion Domains in the Trans-Activity of the Long non-coding RNA ANRIL [ChIRP-seq]

Project description:We performed Chromatin Isolation by RNA Purification (ChIRP-seq) of the lncRNA ANRIL in HEK293 cell line. We identified 3227 genomic regions to be contacted by ANRIL.

2021-05-26 | GSE162221 | GEO

Implication of Repeat Insertion Domains in the Trans-Activity of the Long non-coding RNA ANRIL

Project description:Implication of Repeat Insertion Domains in the Trans-Activity of the Long non-coding RNA ANRIL

| PRJNA681140 | ENA

Implication of repeat insertion domains in the trans-activity of the long non-coding RNA ANRIL [ANRIL_LNA_Affy]

Project description:Implication of repeat insertion domains in the trans-activity of the long non-coding RNA ANRIL [ANRIL_LNA_Affy]

| PRJNA681145 | ENA

Implication of Repeat Insertion Domains in the Trans-Activity of the Long non-coding RNA ANRIL [ANRIL_DEx8_Affy]

Project description:Implication of Repeat Insertion Domains in the Trans-Activity of the Long non-coding RNA ANRIL [ANRIL_DEx8_Affy]

| PRJNA681144 | ENA

Implication of Repeat Insertion Domains in the Trans-Activity of the Long non-coding RNA ANRIL [ChIRP-seq]

Project description:Implication of Repeat Insertion Domains in the Trans-Activity of the Long non-coding RNA ANRIL [ChIRP-seq]

| PRJNA681143 | ENA

The Long Non-Coding RNA ANRIL in Cancers.

Project description:ANRIL (Antisense Noncoding RNA in the INK4 Locus), a long non-coding RNA encoded in the human chromosome 9p21 region, is a critical factor for regulating gene expression by interacting with multiple proteins and miRNAs. It has been found to play important roles in various cellular processes, including cell cycle control and proliferation. Dysregulation of ANRIL has been associated with several diseases like cancers and cardiovascular diseases, for instance. Understanding the oncogenic role of ANRIL and its potential as a diagnostic and prognostic biomarker in cancer is crucial. This review provides insights into the regulatory mechanisms and oncogenic significance of the 9p21 locus and ANRIL in cancer.

| S-EPMC10453084 | biostudies-literature

The clinical significance of long non-coding RNA ANRIL level in diabetic retinopathy.

Project description:AimTo analyse the expression of lncRNA-ANRIL and other related factors in different human body fluids, explore the clinical significance of ANRIL and validate whether ANRIL is interrelated with the renin-angiotensin system and NF-κB signalling pathway.MethodsNinety-one patients were included in this cross-sectional study and were divided into the NDM group (20 patients), DM group (25 patients), NPDR group (21 patients) and PDR group (25 patients). Basic information and samples of serum, aqueous fluid and vitreous fluid were collected before vitrectomy or intravitreal injection. The transcription and levels of ANRIL and other related factors were detected by RT-PCR and ELISA. Statistical Package for Social Sciences software was used for statistical analysis.ResultsANRIL expression varied among different groups and body fluids. There was no difference in ANRIL expression between the NDM and DM groups, but the level of ANRIL was significantly lower in the DM group than in the NPDR and PDR group. In vitreous fluid, ANRIL expression was positively correlated with Ang II, p65 and VEGF expression in the PDR group. The expression of ANRIL in serum was not significantly correlated with age or the random blood sugar but was positively correlated with diabetic duration and HbAc1 level.ConclusionsLevels of lncRNA-ANRIL are higher in DR patient and correlated with the progression of DR that may be used as an indicator to predict the development of DR. The activation of the RAS and the NF-κB pathway may be closely related to the upregulation of ANRIL. Clinical trial number ChiCTR1800017500. Registry Chinese Clinical Trial Registry.

| S-EPMC7093365 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data